CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to ... and CRISPRa-UCP1 system to enable sono-gene therapy for obesity.

Oct. 28, 2024 — Using state-of-the-art technology, researchers have identified several specific steps needed for CRISPR to become active and perform its gene editing ... Sep. 23, 2024 — CRISPR ...

off-target editing, but their improper repair can lead to additional safety concerns when it comes to using CRISPR-Cas9 systems, which have already reached patients. Researchers using CRISPR-Cas9 gene ...

A few companies are using AI to develop gene editing tools that are more specific and more efficacious. CRISPR systems such as CRISPR-Cas9 revolutionized gene editing, but genomic rearrangements ...

In July 2023, Sanofi expanded an existing partnership with Scribe Therapeutics to use its CRISPR-based gene-editing technology to develop both in vivo and ex vivo cancer cell therapies.

CRISPR Therapeutics has positioned itself at the forefront of gene editing technology, focusing on developing transformative therapies for a range of serious conditions. The company's flagship ...